Dilated Cardiomyopathy: From Genetics to Clinical Management
Open accessThe DOI matches its Crossref record; 605 of the 607 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
This open access book presents a multidisciplinary comprehensive overview of dilated cardiomyopathy, from pathophysiology, differential diagnosis work-up, to clinical management. It further highlights open issues such as the clinical use of genetic testing and arrhythmia in dilated cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 607
Juilliere, Y., Barbier, G., Feldmann, L., Grentzinger, A., Danchin, N., & Cherrier, F. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015231 · Cited by 289 · cited 1×
“Biventricular involvement in DCM identifies a subset of patients with poor outcome [107, 108].”
Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy
Jefferies, J. L., Eidem, B. W., Belmont, J. W., Craigen, W. J., Ware, S. M., Fernbach, S. D., Neish, S. R., Smith, E. O., & Towbin, J. A. (2005) · Circulation · doi:10.1161/circulationaha.104.528281 · Cited by 288 · cited 8×
“Late gadolinium enhancement (LGE) at cardiovascular magnetic resonance (CMR) provides an alternative approach and may identify prior myocardial infarction (subendocardial or transmural LGE) in as many as 13% of patients with suspected DCM and unobstructed coronary arteries [5].”
InfluentialSAKAKIBARA, S., & KONNO, S. (1962) · Japanese Heart Journal · doi:10.1536/ihj.3.537 · Cited by 287
Mechanisms of Cardiac Regeneration
Uygur, A., & Lee, R. T. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.01.018 · Cited by 286
aus dem Siepen, F., Buss, S. J., Messroghli, D., Andre, F., Lossnitzer, D., Seitz, S., Keller, M., Schnabel, P. A., Giannitsis, E., Korosoglou, G., et al. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu183 · Cited by 284
Echocardiographic findings in myocarditis
Pinamonti, B., Alberti, E., Cigalotto, A., Dreas, L., Salvi, A., Silvestri, F., & Camerini, F. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90226-3 · Cited by 283
Self-citationHJALMARSON, A., FAGERBERG, S. G. B., WREDEL, H., WAAGSTEIN, F., KJEKSHUS, J., WIKSTRAND, J., EL ALLAF, D., VÍTOVEC, J., ALDERSHIVILE, J., HALINEN, M., et al. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200012000-00023 · Cited by 282
Metavinculin mutations alter actin interaction in dilated cardiomyopathy
Olson, T. M., Illenberger, S., Kishimoto, N. Y., Huttelmaier, S., Keating, M. T., & Jockusch, B. M. (2002) · Circulation · doi:10.1161/hc0402.102930 · Cited by 278 · cited 7×
“• Deficit in protein post-translational modifications (glycosylation processescardiomyopathies): An example comes from dolichol kinase gene mutations, resulting in impairment of protein glycosylation processes inside the cell organelles, thus manifesting as syndromic conditions with hypertrophic phenotype and as non-s…”
InfluentialCardiac sarcoidosis: a comprehensive review
Sekhri, V., Sanal, S., DeLorenzo, L. J., Aronow, W. S., & Maguire, G. P. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.24118 · Cited by 278
Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy
Douglas, P. S., Morrow, R., Ioli, A., & Reichek, N. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90504-4 · Cited by 278
Iles, L. M., Ellims, A. H., Llewellyn, H., Hare, J. L., Kaye, D. M., McLean, C. A., & Taylor, A. J. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu182 · Cited by 278
Determinants of Pulmonary Hypertension in Left Ventricular Dysfunction
Enriquez-Sarano, M., Rossi, A., Seward, J. B., Bailey, K. R., & Tajik, A. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00436-6 · Cited by 276
Doval, H. C., Nul, D. R., Grancelli, H. O., Varini, S. D., Soifer, S., Corrado, G., Dubner, S., Scapin, O., & Perrone, S. V. (1996) · Circulation · doi:10.1161/01.cir.94.12.3198 · Cited by 275
Yancy, C. W., Januzzi, J. L., Allen, L. A., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Jessup, M., Lindenfeld, J., Maddox, T. M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.025 · Cited by 275
Cameli, M., Lisi, M., Mondillo, S., Padeletti, M., Ballo, P., Tsioulpas, C., Bernazzali, S., & Maccherini, M. (2010) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-8-14 · Cited by 274
Vrtovec, B., Poglajen, G., Lezaic, L., Sever, M., Domanovic, D., Cernelc, P., Socan, A., Schrepfer, S., Torre-Amione, G., Haddad, F., et al. (2013) · Circulation Research · doi:10.1161/circresaha.112.276519 · Cited by 273
Cell therapy trials for heart regeneration — lessons learned and future directions
Menasché, P. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0013-0 · Cited by 272
Gutberlet, M., Spors, B., Thoma, T., Bertram, H., Denecke, T., Felix, R., Noutsias, M., Schultheiss, H.-P., & Kühl, U. (2008) · Radiology · doi:10.1148/radiol.2461062179 · Cited by 270 · cited 1×
“However, the sensitivity of the LLC criteria is greatest for patients with infarct-like rather than HF or arrhythmic presentations [19, 20].”
Assessment of Nonischemic Myocardial Fibrosis
Jellis, C., Martin, J., Narula, J., & Marwick, T. H. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.047 · Cited by 269
Pascual-Figal, D. A., Manzano-Fernández, S., Boronat, M., Casas, T., Garrido, I. P., Bonaque, J. C., Pastor-Perez, F., Valdés, M., & Januzzi, J. L. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr047 · Cited by 262
Auricchio, A., Schillinger, W., Meyer, S., Maisano, F., Hoffmann, R., Ussia, G. P., Pedrazzini, G. B., van der Heyden, J., Fratini, S., Klersy, C., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.061 · Cited by 261
Deckers, J. W., Hare, J. M., & Baughman, K. L. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90049-s · Cited by 261 · cited 1×
“The death associated with EMB is possible and can be the result of perforation with pericardial tamponade [11].”
BackgroundNakamori, S., Dohi, K., Ishida, M., Goto, Y., Imanaka-Yoshida, K., Omori, T., Goto, I., Kumagai, N., Fujimoto, N., Ichikawa, Y., et al. (2018) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2017.04.006 · Cited by 260
Bayes-Genis, A., de Antonio, M., Vila, J., Peñafiel, J., Galán, A., Barallat, J., Zamora, E., Urrutia, A., & Lupón, J. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.087 · Cited by 259
Cardiac sarcoidosis: state-of-the-art review
Kouranos, V., & Sharma, R. (2021) · Heart · doi:10.1136/heartjnl-2019-316442 · Cited by 259
Tanaka, H., Nesser, H.-J., Buck, T., Oyenuga, O., Janosi, R. A., Winter, S., Saba, S., & Gorcsan, J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq213 · Cited by 259
Galderisi, M., Cardim, N., D'Andrea, A., Bruder, O., Cosyns, B., Davin, L., Donal, E., Edvardsen, T., Freitas, A., Habib, G., et al. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu323 · Cited by 258
BÉCANE, H., BONNE, G., VARNOUS, S., MUCHIR, A., ORTEGA, V., HAMMOUDA, E. H., URTIZBEREA, J., LAVERGNE, T., FARDEAU, M., EYMARD, B., et al. (2000) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2000.01661.x · Cited by 257
Hutt, D. F., Quigley, A.-M., Page, J., Hall, M. L., Burniston, M., Gopaul, D., Lane, T., Whelan, C. J., Lachmann, H. J., Gillmore, J. D., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu107 · Cited by 250
Consugar, M. B., Navarro-Gomez, D., Place, E. M., Bujakowska, K. M., Sousa, M. E., Fonseca-Kelly, Z. D., Taub, D. G., Janessian, M., Wang, D. Y., Au, E. D., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.172 · Cited by 245
Pogwizd, S. M., McKenzie, J. P., & Cain, M. E. (1998) · Circulation · doi:10.1161/01.cir.98.22.2404 · Cited by 243 · cited 1×
“The fibrous tissue constitutes a substrate for ventricular arrhythmias by inducing slow and heterogeneous conduction, favoring reentrant circuits, and producing vulnerability to life-threatening ventricular tachyarrhythmias [40].”
Pinamonti, B., Zecchin, M., Di Lenarda, A., Gregori, D., Sinagra, G., & Camerini, F. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00539-6 · Cited by 243 · cited 1×
“Thus, reassessment of these patients after 3 months of therapy gives additional prognostic information with respect to the initial evaluation [36].”
Self-citationFrancone, M., Chimenti, C., Galea, N., Scopelliti, F., Verardo, R., Galea, R., Carbone, I., Catalano, C., Fedele, F., & Frustaci, A. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2013.10.011 · Cited by 243
Bilchick, K. C., Dimaano, V., Wu, K. C., Helm, R. H., Weiss, R. G., Lima, J. A., Berger, R. D., Tomaselli, G. F., Bluemke, D. A., Halperin, H. R., et al. (2008) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2008.04.013 · Cited by 242 · cited 1×
“Cardiac dyssynchrony assessed by CMR strain analysis, associated with LGE imaging, was also suggested to better predict improvement in functional class after CRT implantation [105], compared to currently recommended parameters for patient selection [106].”
Halliday, B. P., Cleland, J. G. F., Goldberger, J. J., & Prasad, S. K. (2017) · Circulation · doi:10.1161/circulationaha.116.027134 · Cited by 241
Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy
Goldberger, J. J., Subačius, H., Patel, T., Cunnane, R., & Kadish, A. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.12.021 · Cited by 237
Parsai, C., Bijnens, B., Sutherland, G. R., Baltabaeva, A., Claus, P., Marciniak, M., Paul, V., Scheffer, M., Donal, E., Derumeaux, G., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn481 · Cited by 236
Non–Evidence-Based ICD Implantations in the United States
Al-Khatib, S. M. (2011) · JAMA · doi:10.1001/jama.2010.1915 · Cited by 234
McNair, W. P., Sinagra, G., Taylor, M. R. G., Di Lenarda, A., Ferguson, D. A., Salcedo, E. E., Slavov, D., Zhu, X., Caldwell, J. H., & Mestroni, L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.084 · Cited by 234
Self-citationShan, K., Bick, R. J., Poindexter, B. J., Shimoni, S., Letsou, G. V., Reardon, M. J., Howell, J. F., Zoghbi, W. A., & Nagueh, S. F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00786-5 · Cited by 233
Development of Cardiomyopathy in Female Carriers of Duchenne and Becker Muscular Dystrophies
Politano, L. (1996) · JAMA · doi:10.1001/jama.1996.03530410049032 · Cited by 233 · cited 7×
“Moreover, patients with ARVC can show a left ventricular involvement, and the other way around a DCM relative may demonstrate ventricular ectopy coming from the right ventricle [8].”
InfluentialAndrade, J. P. D., Marin Neto, J. A., Paola, A. A. V. D., Vilas-Boas, F., Oliveira, G. M. M., Bacal, F., Bocchi, E. A., Almeida, D. R., Fragata Filho, A. A., Moreira, M. D. C. V., et al. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011000600002 · Cited by 232
Risk of sports: do we need a pre-participation screening for competitive and leisure athletes?
Corrado, D., Schmied, C., Basso, C., Borjesson, M., Schiavon, M., Pelliccia, A., Vanhees, L., & Thiene, G. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq482 · Cited by 231
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J. C., & Erdmann, E. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.05.046 · Cited by 227
Myocardial T1 and T2 Mapping: Techniques and Clinical Applications
Kim, P. K., Hong, Y. J., Im, D. J., Suh, Y. J., Park, C. H., Kim, J. Y., Chang, S., Lee, H.-J., Hur, J., Kim, Y. J., et al. (2017) · Korean Journal of Radiology · doi:10.3348/kjr.2017.18.1.113 · Cited by 226
Polizzotti, B. D., Ganapathy, B., Walsh, S., Choudhury, S., Ammanamanchi, N., Bennett, D. G., dos Remedios, C. G., Haubner, B. J., Penninger, J. M., & Kühn, B. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5171 · Cited by 225
Leyva, F., Foley, P. W., Chalil, S., Ratib, K., Smith, R. E., Prinzen, F., & Auricchio, A. (2011) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-13-29 · Cited by 225
The MOGE(S) Classification of Cardiomyopathy for Clinicians
Arbustini, E., Narula, N., Tavazzi, L., Serio, A., Grasso, M., Favalli, V., Bellazzi, R., Tajik, J. A., Bonow, R. O., Fuster, V., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.027 · Cited by 224
RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing
Maatz, H., Jens, M., Liss, M., Schafer, S., Heinig, M., Kirchner, M., Adami, E., Rintisch, C., Dauksaite, V., Radke, M. H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74523 · Cited by 221
Merlo, M., Pivetta, A., Pinamonti, B., Stolfo, D., Zecchin, M., Barbati, G., Di Lenarda, A., & Sinagra, G. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.16 · Cited by 220
Self-citationLehrke, S., Lossnitzer, D., Schöb, M., Steen, H., Merten, C., Kemmling, H., Pribe, R., Ehlermann, P., Zugck, C., Korosoglou, G., et al. (2011) · Heart · doi:10.1136/hrt.2010.205542 · Cited by 218
Hershberger, R. E., Cowan, J., Morales, A., & Siegfried, J. D. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.817346 · Cited by 217 · cited 1×
“Contrary to what was believed in the past, in the broad spectrum of DCM, 20–50% forms are now known to be familial [1].”
Stankovic, I., Prinz, C., Ciarka, A., Daraban, A. M., Kotrc, M., Aarones, M., Szulik, M., Winter, S., Belmans, A., Neskovic, A. N., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jev288 · Cited by 215
Mendes, L. A., Dec, G. W., Picard, M. H., Palacios, I. F., Newell, J., & Davidoff, R. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90483-9 · Cited by 213
Prognostic Electrocardiographic Parameters in Patients with Suspected Myocarditis
Ukena, C., Mahfoud, F., Kindermann, I., Kandolf, R., Kindermann, M., & Böhm, M. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq229 · Cited by 212
Prevalence of Desmin Mutations in Dilated Cardiomyopathy
Taylor, M. R. G., Slavov, D., Ku, L., Di Lenarda, A., Sinagra, G., Carniel, E., Haubold, K., Boucek, M. M., Ferguson, D., Graw, S. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.646778 · Cited by 212 · cited 5×
“It is pivotal to exclude possible removable causes of left ventricular dysfunction [4].”
InfluentialSelf-citationvan Bommel, R. J., Marsan, N. A., Delgado, V., Borleffs, C. J. W., van Rijnsoever, E. P. M., Schalij, M. J., & Bax, J. J. (2011) · Circulation · doi:10.1161/circulationaha.110.009803 · Cited by 211
Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Bloma, N., Borggrefe, M., Camm, A. J., Elliot, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2016) · Utrecht University Repository (Utrecht University) · Cited by 211
Bohnen, S., Radunski, U. K., Lund, G. K., Kandolf, R., Stehning, C., Schnackenburg, B., Adam, G., Blankenberg, S., & Muellerleile, K. (2015) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.114.003073 · Cited by 207
Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity
Mestroni, L., Rocco, C., Gregori, D., Sinagra, G., Di Lenarda, A., Miocic, S., Vatta, M., Pinamonti, B., Muntoni, F., Caforio, A. L. P., et al. (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)91449-5 · Cited by 205
Self-citationNeilan, T. G., Coelho-Filho, O. R., Danik, S. B., Shah, R. V., Dodson, J. A., Verdini, D. J., Tokuda, M., Daly, C. A., Tedrow, U. B., Stevenson, W. G., et al. (2013) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2013.05.013 · Cited by 205
Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis
Anzini, M., Merlo, M., Sabbadini, G., Barbati, G., Finocchiaro, G., Pinamonti, B., Salvi, A., Perkan, A., Di Lenarda, A., Bussani, R., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003092 · Cited by 204
Self-citationAβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer’s Disease
Troncone, L., Luciani, M., Coggins, M., Wilker, E. H., Ho, C.-Y., Codispoti, K. E., Frosch, M. P., Kayed, R., & del Monte, F. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.08.073 · Cited by 204
Multiple Biomarkers for Risk Prediction in Chronic Heart Failure
Ky, B., French, B., Levy, W. C., Sweitzer, N. K., Fang, J. C., Wu, A. H. B., Goldberg, L. R., Jessup, M., & Cappola, T. P. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.965020 · Cited by 201
Cardiac amyloidosis: the great pretender
Rapezzi, C., Lorenzini, M., Longhi, S., Milandri, A., Gagliardi, C., Bartolomei, I., Salvi, F., & Maurer, M. S. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9480-0 · Cited by 201
Kahlert, P., Plicht, B., Schenk, I. M., Janosi, R.-A., Erbel, R., & Buck, T. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.02.003 · Cited by 200
Alcoholic Cardiomyopathy: Pathophysiologic Insights
Piano, M. R., & Phillips, S. A. (2014) · Cardiovascular Toxicology · doi:10.1007/s12012-014-9252-4 · Cited by 199
Melacini, P., Fanin, M., Danieli, G. A., Villanova, C., Martinello, F., Miorin, M., Freda, M. P., Miorelli, M., Mostacciuolo, M. L., Fasoli, G., et al. (1996) · Circulation · doi:10.1161/01.cir.94.12.3168 · Cited by 197 · cited 5×
“7-fold increased risk associated with black race [7].”
InfluentialMyocarditis in systemic lupus erythematosus
Wijetunga, M., & Rockson, S. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01223-8 · Cited by 197 · cited 1×
“At echocardiographic studies about 6% of SLE patients showed global hypokinesia [6], and evidence of myocarditis can be found at postmortem examination in approximately 40% of cases [7].”
BackgroundMyocarditis in Clinical Practice
Sinagra, G., Anzini, M., Pereira, N. L., Bussani, R., Finocchiaro, G., Bartunek, J., & Merlo, M. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.05.013 · Cited by 196
Self-citationHaugaa, K. H., Goebel, B., Dahlslett, T., Meyer, K., Jung, C., Lauten, A., Figulla, H. R., Poerner, T. C., & Edvardsen, T. (2012) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2012.02.004 · Cited by 194
Verdonschot, J. A. J., Hazebroek, M. R., Derks, K. W. J., Barandiarán Aizpurua, A., Merken, J. J., Wang, P., Bierau, J., van den Wijngaard, A., Schalla, S. M., Abdul Hamid, M. A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx808 · Cited by 194
Katare, R., Caporali, A., Zentilin, L., Avolio, E., Sala‐Newby, G. B., Oikawa, A., Cesselli, D., Beltrami, A. P., Giacca, M., Emanueli, C., et al. (2011) · Bristol Research (University of Bristol) · doi:10.1161/circresaha · Cited by 193
Begay, R. L., Graw, S. L., Sinagra, G., Asimaki, A., Rowland, T. J., Slavov, D. B., Gowan, K., Jones, K. L., Brun, F., Merlo, M., et al. (2018) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2017.12.003 · Cited by 188
Self-citationSantangeli, P., Muser, D., Maeda, S., Filtz, A., Zado, E. S., Frankel, D. S., Dixit, S., Epstein, A. E., Callans, D. J., & Marchlinski, F. E. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.03.004 · Cited by 185
Quantification of Functional Mitral Regurgitation by Real-Time 3D Echocardiography
Marsan, N. A., Westenberg, J. J. M., Ypenburg, C., Delgado, V., van Bommel, R. J., Roes, S. D., Nucifora, G., van der Geest, R. J., de Roos, A., Reiber, J. C., et al. (2009) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.07.006 · Cited by 184
Pathogeneses of Sudden Cardiac Death in National Collegiate Athletic Association Athletes
Harmon, K. G., Drezner, J. A., Maleszewski, J. J., Lopez-Anderson, M., Owens, D., Prutkin, J. M., Asif, I. M., Klossner, D., & Ackerman, M. J. (2014) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001376 · Cited by 184
Frantz, S., Falcao-Pires, I., Balligand, J.-L., Bauersachs, J., Brutsaert, D., Ciccarelli, M., Dawson, D., de Windt, L. J., Giacca, M., Hamdani, N., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1138 · Cited by 184
Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects
Calabrese, F. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00475-9 · Cited by 184 · cited 1×
“Conversely, the value of EMB is questionable in patients presenting with low-risk syndromes and responding to standard care [8].”
BackgroundChalil, S., Foley, P. W. X., Muyhaldeen, S. A., Patel, K. C. R., Yousef, Z. R., Smith, R. E. A., Frenneaux, M. P., & Leyva, F. (2007) · Europace · doi:10.1093/europace/eum133 · Cited by 184
Muser, D., Santangeli, P., Castro, S. A., Pathak, R. K., Liang, J. J., Hayashi, T., Magnani, S., Garcia, F. C., Hutchinson, M. D., Supple, G. G., et al. (2016) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004328 · Cited by 184
Rüssel, I. K., Götte, M. J. W., Bronzwaer, J. G., Knaapen, P., Paulus, W. J., & van Rossum, A. C. (2009) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.03.001 · Cited by 183
Bennett, M. K., Gilotra, N. A., Harrington, C., Rao, S., Dunn, J. M., Freitag, T. B., Halushka, M. K., & Russell, S. D. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000087 · Cited by 182
Mutations of Presenilin Genes in Dilated Cardiomyopathy and Heart Failure
Li, D., Parks, S. B., Kushner, J. D., Nauman, D., Burgess, D., Ludwigsen, S., Partain, J., Nixon, R. R., Allen, C. N., Irwin, R. P., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/509900 · Cited by 182 · cited 1×
“• Protein misfolding disease: Mutations in presenilin genes have been recently identified in patients with DCM [13].”
BackgroundLong-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators
Betensky, B. P., Tschabrunn, C. M., Zado, E. S., Goldberg, L. R., Marchlinski, F. E., Garcia, F. C., & Cooper, J. M. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.02.010 · Cited by 180
Haqqani, H. M., Tschabrunn, C. M., Tzou, W. S., Dixit, S., Cooper, J. M., Riley, M. P., Lin, D., Hutchinson, M. D., Garcia, F. C., Bala, R., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.03.008 · Cited by 180
Prevalence of Desmosomal Protein Gene Mutations in Patients With Dilated Cardiomyopathy
Elliott, P., O'Mahony, C., Syrris, P., Evans, A., Rivera Sorensen, C., Sheppard, M. N., Carr-White, G., Pantazis, A., & McKenna, W. J. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.937805 · Cited by 178
Vrtovec, B., Poglajen, G., Lezaic, L., Sever, M., Socan, A., Domanovic, D., Cernelc, P., Torre-Amione, G., Haddad, F., & Wu, J. C. (2013) · Circulation · doi:10.1161/circulationaha.112.000230 · Cited by 177
Lazarević, A. M., Nakatani, S., Nešković, A. N., Marinković, J., Yasumura, Y., Stojičić, D., Miyatake, K., Bojić, M., & Popović, A. D. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00565-9 · Cited by 174 · cited 1×
“Echocardiography is able to detect subclinical changes in cardiac function, which occur in the early stages of the disease, as abnormal Doppler transmitral flow pattern, indicating impaired left ventricle relaxation; changes in left ventricle volume before the changes in cardiac mass and impairment of diastolic fillin…”
BackgroundSoriano, C. J., Ridocci, F., Estornell, J., Jimenez, J., Martinez, V., & De Velasco, J. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.037 · Cited by 174 · cited 1×
“Mid-wall LGE was found in 10–28% of patients with DCM [13, 15].”
Rossi, A., Temporelli, P. L., Quintana, M., Dini, F. L., Ghio, S., Hillis, G. S., Klein, A. L., Ajmone Marsan, N., Prior, D. L., Yu, C. M., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp112 · Cited by 173 · cited 1×
“Left atrial enlargement is associated with adverse outcome in patients with DCM [111, 112].”
Exner, D. V., Dries, D. L., Waclawiw, M. A., Shelton, B., & Domanski, M. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00675-5 · Cited by 172 · cited 1×
“– Asymptomatic left ventricular systolic dysfunction: in patients with depressed LV systolic function in the absence of symptoms, onset of HF should be delayed or prevented primarily by controlling hypertension [28] and, when the LVEF is ≤40%, by initiating angiotensin-converting enzyme inhibitor (ACEi) therapy [29] p…”
Refaat, M. M., Lubitz, S. A., Makino, S., Islam, Z., Frangiskakis, J. M., Mehdi, H., Gutmann, R., Zhang, M. L., Bloom, H. L., MacRae, C. A., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2011.10.016 · Cited by 172
Perazzolo Marra, M., De Lazzari, M., Zorzi, A., Migliore, F., Zilio, F., Calore, C., Vettor, G., Tona, F., Tarantini, G., Cacciavillani, L., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.01.014 · Cited by 171
Genetics of inherited cardiomyopathy
Jacoby, D., & McKenna, W. J. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr260 · Cited by 171
Mahon, N. G., Murphy, R. T., MacRae, C. A., Caforio, A. L. P., Elliott, P. M., & McKenna, W. J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-2-200507190-00009 · Cited by 170 · cited 1×
“Recent studies, which assessed for hereditary disease with prospective pedigree analysis and echocardiography, have suggested that up to 40% of DCM may be inherited.(10,11) Accordingly, the importance of considering familial disease in DCM has been emphasized in recent consensus statements.”
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00084-9 · Cited by 168
Richardson, M., Freemantle, N., Calvert, M. J., Cleland, J. G. F., Tavazzi, L., & on behalf of the CARE-HF Study Steering Committee and Investigators (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm192 · Cited by 167
Guzzo-Merello, G. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i8.771 · Cited by 163
Viollet, L., Thrush, P. T., Flanigan, K. M., Mendell, J. R., & Allen, H. D. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.02.064 · Cited by 162
Kubanek, M., Sramko, M., Maluskova, J., Kautznerova, D., Weichet, J., Lupinek, P., Vrbska, J., Malek, I., & Kautzner, J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.072 · Cited by 161
The Inflammasome in Myocardial Injury and Cardiac Remodeling
Toldo, S., Mezzaroma, E., Mauro, A. G., Salloum, F., Van Tassell, B. W., & Abbate, A. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5989 · Cited by 160
Idiopathic cardiomyopathy in the United States, 1970–1982
Gillum, R. F. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90111-0 · Cited by 159
Cardiac Involvement in Hemochromatosis
Gulati, V., Harikrishnan, P., Palaniswamy, C., Aronow, W. S., Jain, D., & Frishman, W. H. (2013) · Cardiology in Review · doi:10.1097/crd.0b013e3182a67805 · Cited by 159
Cardiac sarcoidosis: Diagnostic, prognostic, and therapeutic considerations
Sekiguchi, M., Yazaki, Y., Isobe, M., & Hiroe, M. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00050989 · Cited by 159 · cited 1×
“Interestingly, cardiac involvement is present in about 25% of patients with systemic sarcoidosis [17], but symptoms referable to cardiac sarcoidosis occur in only 5% of sarcoid patients [18, 19], and up to 50% of patients with granulomatous inflammation in the heart have no evidence of extracardiac disease.”
BackgroundCorrado, D., Basso, C., Pilichou, K., & Thiene, G. (2010) · Heart · doi:10.1136/hrt.2010.193276 · Cited by 159
Fischer-Rasokat, U., Assmus, B., Seeger, F. H., Honold, J., Leistner, D., Fichtlscherer, S., Schächinger, V., Tonn, T., Martin, H., Dimmeler, S., et al. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.855023 · Cited by 159
Meijers, W. C., Januzzi, J. L., deFilippi, C., Adourian, A. S., Shah, S. J., van Veldhuisen, D. J., & de Boer, R. A. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.02.011 · Cited by 158
Gullapalli, R. R., Desai, K. V., Santana-Santos, L., Kant, J. A., & Becich, M. J. (2012) · Journal of Pathology Informatics · doi:10.4103/2153-3539.103013 · Cited by 157
MR features of arrhythmogenic right ventricular dysplasia.
Blake, L. M., Scheinman, M. M., & Higgins, C. B. (1994) · American Journal of Roentgenology · doi:10.2214/ajr.162.4.8140995 · Cited by 156
Pathophysiology, diagnosis and treatment of tachycardiomyopathy
Martin, C., & Lambiase, P. D. (2017) · Heart · doi:10.1136/heartjnl-2016-310391 · Cited by 156
Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy
Fauchier, L. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1761 · Cited by 154 · cited 1×
“The natural history of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy has been a highly controversial issue [38, 39].”
BackgroundGender-Specific Differences in Major Cardiac Events and Mortality in Lamin A/C Mutation Carriers
van Rijsingen, I. A. W., Nannenberg, E. A., Arbustini, E., Elliott, P. M., Mogensen, J., Hermans-van Ast, J. F., van der Kooi, A. J., van Tintelen, J. P., van den Berg, M. P., Grasso, M., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs191 · Cited by 151
Pavlicek, M., Wahl, A., Rutz, T., de Marchi, S. F., Hille, R., Wustmann, K., Steck, H., Eigenmann, C., Schwerzmann, M., & Seiler, C. (2011) · European Journal of Echocardiography · doi:10.1093/ejechocard/jer138 · Cited by 151
Felker, G. M., Fiuzat, M., Thompson, V. P., Shaw, L. K., Neely, M. L., Adams, K. F., Whellan, D. J., Donahue, M., Ahmad, T., Kitzman, D. W., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000207 · Cited by 149
Lupón, J., de Antonio, M., Vila, J., Peñafiel, J., Galán, A., Zamora, E., Urrutia, A., & Bayes-Genis, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085466 · Cited by 148
Peri-interventional echo assessment for the MitraClip procedure
Wunderlich, N. C., & Siegel, R. J. (2013) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jet060 · Cited by 148
Natural History and Prognostic Factors in Alcoholic Cardiomyopathy
Guzzo-Merello, G., Segovia, J., Domínguez, F., Marcos, M. C., Gómez-Bueno, M. F., Avellana, P., Millán, I., Alonso‐Pulpón, L., & García‐Pavía, P. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.07.014 · Cited by 145
Hung, J., Koelling, T. M., Semigran, M. J., Dec, G. W., Levine, R. A., & Salvo, T. G. D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00624-9 · Cited by 145
Tanaka, H., Hara, H., Saba, S., & Gorcsan, J. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.09.010 · Cited by 145
Wu, A. H. B., Wians, F. H., & Jaffe, A. S. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.02.029 · Cited by 142
Ban, J.-E., Park, H.-C., Park, J.-S., Nagamoto, Y., Choi, J.-I., Lim, H.-E., Park, S.-W., & Kim, Y.-H. (2013) · EP Europace · doi:10.1093/europace/eus371 · Cited by 141
Leong, D. P., Chakrabarty, A., SHIPP, N. J., Molaee, P., Madsen, P. L., Joerg, L., Sullivan, T., Worthley, S. G., Pasquale, C. G. D., Sanders, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr391 · Cited by 141
Strategies for Cardiac Regeneration and Repair
Lin, Z., & Pu, W. T. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3006681 · Cited by 141
MARSAN, N. A., BLEEKER, G. B., YPENBURG, C., GHIO, S., VAN DE VEIRE, N. R., HOLMAN, E. R., VAN DER WALL, E. E., TAVAZZI, L., SCHALIJ, M. J., & BAX, J. J. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.01056.x · Cited by 140
Singh, S. N., Fisher, S. G., Carson, P. E., & Fletcher, R. D. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00338-6 · Cited by 139
Spezzacatene, A., Sinagra, G., Merlo, M., Barbati, G., Graw, S. L., Brun, F., Slavov, D., Di Lenarda, A., Salcedo, E. E., Towbin, J. A., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002149 · Cited by 139
Self-citationCleland, J. G. F., Calvert, M., Verboven, Y., & Freemantle, N. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.11.006 · Cited by 138 · cited 1×
“Since then, many trials have demonstrated that CRT, in appropriately selected patients, reduces mortality and morbidity [58] and improves systolic function, symptoms, and quality of life [59, 60].”
Waßmuth, R., Prothmann, M., Utz, W., Dieringer, M. A., von Knobelsdorff‐Brenkenhoff, F., Greiser, A., & Schulz‐Menger, J. (2013) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-15-27 · Cited by 136
Saksena, S., Slee, A., Waldo, A. L., Freemantle, N., Reynolds, M., Rosenberg, Y., Rathod, S., Grant, S., Thomas, E., & Wyse, D. G. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.07.036 · Cited by 135
Schmidt, B., Chun, K. R. J., Baensch, D., Antz, M., Koektuerk, B., Tilz, R. R., Metzner, A., Ouyang, F. O., & Kück, K. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.08.010 · Cited by 135
Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score
Lupón, J., Gaggin, H. K., de Antonio, M., Domingo, M., Galán, A., Zamora, E., Vila, J., Peñafiel, J., Urrútia, A., Ferrer, E., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.019 · Cited by 132
Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis
Belkaya, S., Kontorovich, A. R., Byun, M., Mulero-Navarro, S., Bajolle, F., Cobat, A., Josowitz, R., Itan, Y., Quint, R., Lorenzo, L., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.043 · Cited by 132
Keith, M. C. L., & Bolli, R. (2015) · Circulation Research · doi:10.1161/circresaha.116.305557 · Cited by 132
Cardiac features of Emery–Dreifuss muscular dystrophy caused by lamin A/C gene mutations
Sanna, T., Russo, A. D., Toniolo, D., Vytopil, M., Pelargonio, G., Martino, G. D., Ricci, E., Silvestri, G., Giglio, V., Messano, L., et al. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.020 · Cited by 132
Chalil, S., Stegemann, B., Muhyaldeen, S., Khadjooi, K., Foley, P. W. X., Smith, R., & Leyva, F. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00841.x · Cited by 131 · cited 1×
“Moreover, pacing a transmural scar was associated with a worse outcome than pacing a subendocardial scar [69].”
Katare, R., Caporali, A., Zentilin, L., Avolio, E., Sala-Newby, G., Oikawa, A., Cesselli, D., Beltrami, A. P., Giacca, M., Emanueli, C., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.239111 · Cited by 130
Chen, Z., Sohal, M., Voigt, T., Sammut, E. C., Tobon‐Gomez, C., Child, N., Jackson, T., Shetty, A., Bostock, J., Cooklin, M., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.12.020 · Cited by 129
Dealing with surgical left ventricular assist device complications.
Kilic, A., Acker, M. A., & Atluri, P. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.10.64 · Cited by 129
Besler, C., Lang, D., Urban, D., Rommel, K.-P., von Roeder, M., Fengler, K., Blazek, S., Kandolf, R., Klingel, K., Thiele, H., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003804 · Cited by 129
Gulati, A., Ismail, T. F., Jabbour, A., Ismail, N. A., Morarji, K., Ali, A., Raza, S., Khwaja, J., Brown, T. D. H., Liodakis, E., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft019 · Cited by 128
Satoh, H. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i7.585 · Cited by 127
Advanced Imaging of Cardiac Sarcoidosis
Schatka, I., & Bengel, F. M. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.115121 · Cited by 127
Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy
Hazebroek, M. R., Moors, S., Dennert, R. M., van den Wijngaard, A., Krapels, I. P. C., Hoos, M. B., Verdonschot, J. A. J., Merken, J. J., de Vries, B., Wolffs, P. F. G., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.023 · Cited by 125
Right ventricular function in patients with preserved and reduced ejection fraction heart failure
Puwanant, S., Priester, T. C., Mookadam, F., Bruce, C. J., Redfield, M. M., & Chandrasekaran, K. (2009) · European Journal of Echocardiography · doi:10.1093/ejechocard/jep052 · Cited by 125
Effect of vasodilator therapy on mortality in chronic congestive heart failure
Cohn, J. N., & The Veterans Administration Cooperative Study Group (1988) · European Heart Journal · doi:10.1093/eurheartj/9.suppl_a.171 · Cited by 124
Epidemiology of dilated cardiomyopathy: A prospective post-mortem study of 5252 necropsies
Rakar, S., Sinagra, G., Lenarda, A. D., Poletti, A., Bussani, R., Silvestri, F., Camerini, F., & the Heart Muscle Disease Study Group (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015092 · Cited by 124
Self-citationThe Prognostic Impact of the Evolution of RV Function in Idiopathic DCM
Merlo, M., Gobbo, M., Stolfo, D., Losurdo, P., Ramani, F., Barbati, G., Pivetta, A., Lenarda, A. D., Anzini, M., Gigli, M., et al. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2016.01.027 · Cited by 123
Self-citationJunker, A., Thayssen, P., NIELSEN, B. L., & Andersen, P. E. (2008) · Cardiology · doi:10.1159/000175942 · Cited by 121
Wollert, K. C., Studer, R., von Bülow, B., & Drexler, H. (1994) · Circulation · doi:10.1161/01.cir.90.5.2457 · Cited by 121 · cited 1×
“ACEi [29, 32, 33], ARB [34, 35], beta-blocker [36–38], and MRA [39, 40] have demonstrated, in several clinical trials, to reduce risk of HF hospitalization and death in patient with HF and reduced EF.”
Mueller, K. A. L., Mueller, I. I., Eppler, D., Zuern, C. S., Seizer, P., Kramer, U., Koetter, I., Roecken, M., Kandolf, R., Gawaz, M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126707 · Cited by 120
Gopal, A. S., Schnellbaecher, M. J., Shen, Z., Boxt, L. M., Katz, J., & King, D. L. (1997) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(97)70045-2 · Cited by 118
Masci, P. G., Doulaptsis, C., Bertella, E., Torto, A. D., Symons, R., Pontone, G., Barison, A., Droogné, W., Andreini, D., Lorenzoni, V., et al. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000996 · Cited by 116
Genetic causes of dilated cardiomyopathy
Mestroni, L., Brun, F., Spezzacatene, A., Sinagra, G., & Taylor, M. R. G. (2014) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2014.10.003 · Cited by 114
Self-citationEffects of Intracoronary Stem Cell Transplantation in Patients With Dilated Cardiomyopathy
Vrtovec, B., Poglajen, G., Sever, M., Ležaić, L., Domanović, D., Černelč, P., Haddad, F., & Torre‐Amione, G. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.11.007 · Cited by 114
Is the Outcome of Cardiac Resynchronization Therapy Related to the Underlying Etiology?
Gasparini, M., Mantica, M., Galimberti, P., Genovese, L., Pini, D., Faletra, F. F., Marchesina, U. L., Mangiavacchi, M., Klersy, C., & Gronda, E. (2003) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2003.00011.x · Cited by 114 · cited 1×
“Reverse remodeling is one of the most important mechanisms of action of CRT, but not all patients respond successfully: patients with nonischemic etiology have greater improvement in LV function and decrease in NYHA class after CRT [65].”
Shimada, Y. J., & Shiota, T. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.08.058 · Cited by 113
Khan, N. K., Goode, K. M., Cleland, J. G. F., Rigby, A. S., Freemantle, N., Eastaugh, J., Clark, A. L., de Silva, R., Calvert, M. J., Swedberg, K., et al. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.11.003 · Cited by 113 · cited 1×
“Approximately 30% of patients with HF and LV systolic function impairment have a wide QRS complex on the surface electrocardiogram [55], and cumulative mortality increases proportionally with QRS duration [56].”
D’Andrea, A., Caso, P., Romano, S., Scarafile, R., Cuomo, S., Salerno, G., Riegler, L., Limongelli, G., Salvo, G. D., Romanò, M., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.11.102 · Cited by 113
Diabetic cardiomyopathy: Myth or reality?
Ernande, L., & Dérumeaux, G. (2012) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2011.11.007 · Cited by 112
Piers, S. R. D., Leong, D. P., van Taxis, C. F. B. V. H., Tayyebi, M., Trines, S. A. I. P., Pijnappels, D. A., Delgado, V., Schalij, M. J., & Zeppenfeld, K. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000089 · Cited by 111
Quantitative Assessment of Mitral Regurgitation
Thavendiranathan, P., Phelan, D. M. J., Collier, P. H., Thomas, J. D., Flamm, S. D., & Marwick, T. H. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.07.013 · Cited by 110
Dini, F. L., Cortigiani, L., Baldini, U., Boni, A., Nuti, R., Barsotti, L., & Micheli, G. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02290-1 · Cited by 110 · cited 1×
“Left atrial enlargement is associated with adverse outcome in patients with DCM [111, 112].”
Cooper, L. T., Mather, P. J., Alexis, J. D., Pauly, D. F., Torre-Amione, G., Wittstein, I. S., Dec, G. W., Zucker, M., Narula, J., Kip, K., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.09.009 · Cited by 110
The role of mutations in the SCN5A gene in cardiomyopathies
Zaklyazminskaya, E. V., & Sl, D. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.02.014 · Cited by 110
Thuny, F., Jacquier, A., Jop, B., Giorgi, R., Gaubert, J., Bartoli, J., Moulin, G., & Habib, G. (2010) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2010.01.002 · Cited by 109
Whitlock, M. C., Garg, A., Gelow, J. M., Jacobson, T., & Broberg, C. S. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.065 · Cited by 109
Estimating the Long-Term Treatment Benefits of Sacubitril–Valsartan
Claggett, B., Packer, M., McMurray, J. J. V., Swedberg, K., Rouleau, J., Zile, M. R., Jhund, P., Lefkowitz, M., Shi, V., & Solomon, S. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1509753 · Cited by 108
Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies
Sisakian, H. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i6.478 · Cited by 107
Iwakura, K., Ito, H., Kawano, S., Okamura, A., Kurotobi, T., Date, M., Inoue, K., & Fujii, K. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.065 · Cited by 107
Myocardial involvement in Chagas disease: Insights from cardiac magnetic resonance
Regueiro, A., García‐Álvarez, A., Sitges, M., Ortiz-Pérez, J. T., Caralt, M. T., Pinazo, M., Posada, E., Heras, M., Gascón, J., & Sanz, G. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.089 · Cited by 107
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
Robinson, S. T. (2002) · Survey of Anesthesiology · doi:10.1097/00132586-200208000-00009 · Cited by 106
Mildly dilated congestive cardiomyopathy.
Keren, A., Billingham, M. E., Weintraub, D. S., Stinson, E. B., & Popp, R. L. (1985) · Circulation · doi:10.1161/01.cir.72.2.302 · Cited by 102
BAG3: a new player in the heart failure paradigm
Knezevic, T., Myers, V. D., Gordon, J., Tilley, D. G., Sharp, T. E., Wang, J., Khalili, K., Cheung, J. Y., & Feldman, A. M. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9487-6 · Cited by 99
Interstitial fibrosis in the dilated non-ischaemic myocardium: Table 1
Brooks, A., Schinde, V., Bateman, A. C., & Gallagher, P. J. (2003) · Heart · doi:10.1136/heart.89.10.1255 · Cited by 99 · cited 1×
“gradually and randomly, leading to irreversible replacement fibrosis [42, 71].”
Ferro, M. D., Stolfo, D., Altinier, A., Gigli, M., Perrieri-Montanino, M., Ramani, F., Barbati, G., Pivetta, A., Brun, F., Monserrat, L., et al. (2017) · Heart · doi:10.1136/heartjnl-2016-311017 · Cited by 99
Self-citationPueschner, A., Chattranukulchai, P., Heitner, J. F., Shah, D. J., Hayes, B. D., Rehwald, W. G., Parker, M. A., Kim, H. W., Judd, R. M., Kim, R. J., et al. (2017) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2017.06.013 · Cited by 99
The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) Trial
Seth, S., Bhargava, B., Narang, R., Ray, R., Mohanty, S., Gulati, G. S., Kumar, L., Airan, B., & Venugopal, P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.070 · Cited by 98
Wahbi, K., Babuty, D., Probst, V., Wissocque, L., Labombarda, F., Porcher, R., Bécane, H. M., Lazarus, A., Béhin, A., Laforêt, P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw569 · Cited by 98
Severe Myocardial Fibrosis Caused by a Deletion of the 5’ End of the Lamin A/C Gene
van Tintelen, J. P., Tio, R. A., Kerstjens‐Frederikse, W. S., van Berlo, J. H., Boven, L. G., Suurmeijer, A. J. H., White, S. J., den Dunnen, J. T., Meerman, G. J. T., Vos, Y. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.063 · Cited by 98 · cited 1×
“The overt phase of systolic dysfunction is usually associated with LV dilatation, but this may be absent in some cases causing diagnostic confusion (described in Lamin A/C gene mutation carriers [4, 5] and also in some patients without a known genetic cause [6–8] (Fig.”
Developmental origin and lineage plasticity of endogenous cardiac stem cells
Santini, M. P., Forte, E., Harvey, R. P., & Kovacic, J. C. (2016) · Development · doi:10.1242/dev.111591 · Cited by 98
Mapping the Future of Cardiac MR Imaging: Case-based Review of T1 and T2 Mapping Techniques
Hamlin, S. A., Henry, T. S., Little, B. P., Lerakis, S., & Stillman, A. E. (2014) · Radiographics · doi:10.1148/rg.346140030 · Cited by 97
Mahrholdt, H., Goedecke, C., & Wagner, A. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.06.048 · Cited by 97
Alcohol and arrhythmias: a comprehensive review
George, A., & Figueredo, V. M. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328334b42d · Cited by 95
Does sports activity enhance the risk of sudden death in adolescents and young adults?
Corrado, D., Basso, C., Rizzoli, G., Schiavon, M., & Thiene, G. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.02.064 · Cited by 95
Pathophysiology and Etiology of Heart Failure
Johnson, F. L. (2013) · Cardiology Clinics · doi:10.1016/j.ccl.2013.09.015 · Cited by 95
Lakdawala, N. K., Thune, J. J., Colan, S. D., Cirino, A. L., Farrohi, F., Rivero, J., McDonough, B. A., Sparks, E. A., Orav, E. J., Seidman, J. G., et al. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.962761 · Cited by 92
Garcia-Pavia, P., Syrris, P., Salas, C., Evans, A., Mirelis, J. G., Cobo-Marcos, M., Vilches, C., Bornstein, B., Segovia, J., Alonso-Pulpon, L., et al. (2011) · Heart · doi:10.1136/hrt.2011.227967 · Cited by 92
Role of Titin Missense Variants in Dilated Cardiomyopathy
Begay, R. L., Graw, S., Sinagra, G., Merlo, M., Slavov, D., Gowan, K., Jones, K. L., Barbati, G., Spezzacatene, A., Brun, F., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002645 · Cited by 91
Self-citationKeren, A., Gottlieb, S., Tzivoni, D., Stern, S., Yarom, R., Billingham, M. E., & Popp, R. L. (1990) · Circulation · doi:10.1161/01.cir.81.2.506 · Cited by 90
Francone, M. (2014) · ISRN Radiology · doi:10.1155/2014/365404 · Cited by 89
Shiota, T., McCarthy, P. M., White, R. D., Qin, J. X., Greenberg, N. L., Flamm, S. D., Wong, J., & Thomas, J. D. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00500-7 · Cited by 89
Cardiomyopathy in western Denmark.
Bagger, J. P., Baandrup, U. T., Rasmussen, K., Møller, M., & Vesterlund, T. (1984) · Heart · doi:10.1136/hrt.52.3.327 · Cited by 89
Long-Term Reverse Remodeling With Cardiac Resynchronization Therapy
Verhaert, D., Grimm, R. A., Puntawangkoon, C., Wolski, K., De, S. K., Wilkoff, B. L., Starling, R. C., Tang, W. H. W., Thomas, J. D., & Popović, Z. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.022 · Cited by 88
Guarita-Souza, L. C., de Carvalho, K. A. T., Woitowicz, V., Rebelatto, C., Senegaglia, A. C., Suss, P. H., Miyague, N. I., Francisco, J. C., Olandoski, M., Faria‐Neto, J. R., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.000646 · Cited by 88 · cited 1×
“anthracycline-induced cardiomyopathy [20] and chagasic cardiomyopathy [21]).”
Sade, L. E., Demir, Ö., Atar, İ., Müderrisoğlu, H., & Özin, B. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.069 · Cited by 86
Roifman, I., Connelly, K. A., Wright, G. A., & Wijeysundera, H. C. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.01.011 · Cited by 86
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy
Vergaro, G., Franco, A. D., Giannoni, A., Prontera, C., Ripoli, A., Barison, A., Masci, P. G., Aquaro, G. D., Solal, A. C., Padeletti, L., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.008 · Cited by 85
Prevalence of overt dilated cardiomyopathy in two regions of England.
Williams, D. G., & Olsen, E. G. J. (1985) · Heart · doi:10.1136/hrt.54.2.153 · Cited by 84
Research works printed but not linked: 77
- [426]Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation. 2010;122:900-9.
- [428]Chimenti C, Frustaci A. Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period. Circulation. 2013;128:1531-41.
- [435]Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;128(16):e240-327.
- [437]Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Wojciechowska C, Glanowska G, Wilczewski P, et al. Randomized, placebo-controlled study for immunosuppressive treat- ment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation. 2001;104(1):39-45.
- [447]Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006;113:876-90.
- [448]Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, et al. Update on myocar- ditis. J Am Coll Cardiol. 2012;59:779-92.
- [454]Towbin JA, Lorts A. Arrhythmias and dilated cardiomyopathy common pathogenetic path- ways? J Am Coll Cardiol. 2011;57(21):2169-71.
- [478]Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221-30.
- [482]Goldberger JJ, Subačius H, Patel T, Cunnane R, Kadish AH. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2014;63(18):1879-89.
- [484]Arbustini E, Disertori M, Narula J. Primary prevention of sudden arrhythmic death in dilated cardiomyopathy current guidelines and risk stratification. JACC Heart Fail. 2017;5(1):39-43.
- [486]van Rijsingen IA, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast JF, van der Kooi AJ, et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59(5):493-500.
- [487]Phillips E, Levine SA. Auricular fibrillation without other evidence of heart disease; a cause of reversible heart failure. Am J Med. 1949;7(4):478-89.
- [488]Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol. 1996;19(1):95-106.
- [489]Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management. J Am Coll Cardiol. 2015;66(15):1714-28.
- [493]Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016;133(17):1637-44.
- [494]Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358(25):2667-77.
- [497]Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol. 2006;48(11):2340-7.
- [498]Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118(24):2498-505.
- [500]Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417-27.
- [504]Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation. 2009;120(22):2170-6.
- [506]Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta- blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA. 2006;295(2):165-71.
- [516]Nakahara S, Tung R, Ramirez RJ, Michowitz Y, Vaseghi M, Buch E, et al. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol. 2010;55(21):2355-65.
- [521]Dinov B, Fiedler L, Schönbauer R, Bollmann A, Rolf S, Piorkowski C, et al. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy. Circulation. 2014;129:728-36.
- [522]Oloriz T, Silberbauer J, Maccabelli G, Mizuno H, Baratto F, Kirubakaran S, et al. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus infero- lateral scar sub-types. Circ Arrhythm Electrophysiol. 2014;7(3):414-23.
- [523]Dinov B, Arya A, Schratter A, Schirripa V, Fiedler L, Sommer P, et al. Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality? Circ Arrhythm Electrophysiol. 2015;8(3):598-605.
- [524]Yu R, Ma S, Tung R, Stevens S, Macias C, Bradfield J, et al. Catheter ablation of scar-based ventricular tachycardia: relationship of procedure duration to outcomes and hospital mortality. Heart Rhythm. 2015;12(1):86-94.
- [525]Gökoğlan Y, Mohanty S, Gianni C, Santangeli P, Trivedi C, Güneş MF, et al. Scar homog- enization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol. 2016;68(18):1990-8.
- [526]Santangeli P, Muser D, Zado ES, Magnani S, Khetpal S, Hutchinson MD, et al. Acute hemo- dynamic decompensation during catheter ablation of scar-related ventricular tachycardia: inci- dence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol. 2015;8(1):68-75.
- [527]Muser D, Liang JJ, Castro SA, Hayashi T, Enriquez A, Troutman GS, et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergo- ing catheter ablation of scar-related ventricular tachycardia: a propensity-matched analysis. Heart Rhythm. 2018;15(10):1500-6.
- [529]Piers SR, Tao Q, van Huls van Taxis CF, Schalij MJ, van der Geest RJ, Zeppenfeld K. Contrast- enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonisch- emic cardiomyopathy: implications for the ablation strategy. Circ Arrhythm Electrophysiol. 2013;6(5):875-83.
- [530]Hayashi T, Santangeli P, Pathak RK, Muser D, Liang JJ, Castro SA, et al. Outcomes of catheter ablation of idiopathic outflow tract ventricular arrhythmias with an R wave pattern break in lead V2: a distinct clinical entity. J Cardiovasc Electrophysiol. 2017;28(5):504-14.
- [531]Berruezo A, Mont L, Nava S, Chueca E, Bartholomay E, Brugada J. Electrocardiographic rec- ognition of the epicardial origin of ventricular tachycardias. Circulation. 2004;109(15):1842-7.
- [532]Shun-Shin MJ, Zheng SL, Cole GD, Howard JP, Whinnett ZI, Francis DP. Implantable car- dioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials. Eur Heart J. 2017;38(22):1738-46.
- [571]Merlo M, Pyxaras SA, Pinamonti B, Barbati G, Di Lenarda A, Sinagra G. Prevalence and prog- nostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol. 2011;57:1468-76. https://doi.org/10.1016/j. jacc.2010.11.030. · doi:10.1016/j
- [604]Sinagra G, Anzini M, Pereira NL, Bussani R, Finocchiaro G, Bartunek J, et al. Myocarditis in clinical practice. Mayo Clin Proc. 2016;91(9):1256-66. https://doi.org/10.1016/j. mayocp.2016.05.013. · doi:10.1016/j
- [653]Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. JAMA. 1996;276(3):199.
- [658]Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115(12):1643-455.
- [667]Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guide- lines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200. https://doi.org/10.1093/eurheartj/ ehw128. · doi:10.1093/eurheartj/
- [677]McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin- neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993-1004. https://doi.org/10.1056/NEJMoa1409077. · DOI · Paper page
- [687]Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defi- brillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-8.
- [689]Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E, et al. Defibrillator implanta- tion in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221-30. https://doi.org/10.1056/NEJMoa1608029. · DOI · Paper page
- [692]Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. Department of Veterans Affairs Survival Trial of antiarrhythmic therapy in congestive heart failure. QRS duration and mortal- ity in patients with congestive heart failure. Am Heart J. 2002;143(6):1085-91.
- [706]Stolfo D, Merlo M, Pinamonti B, Poli S, Gigli M, Barbati G, et al. Early improvement of func- tional mitral regurgitation in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2015;115(8):1137-43. https://doi.org/10.1016/j.amjcard.2015.01.549. · DOI
- [718]Merlo M, Anzini M, Bussani R, Artico J, Barbati G, Stolfo D, et al. Characterization and long- term prognosis of postmyocarditic dilated cardiomyopathy compared with idiopathic dilated cardiomyopathy. Am J Cardiol. 2016;118:895-900.
- [726]Priori SG, Blomström-Lundqvist C, Mazzanti A. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;8:746-837.
- [728]Dal Ferro M, Stolfo D, Altinier A, Gigli M, Perrieri M, Ramani F, et al. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy. Heart. 2017;103:1704-10.
- [735]Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10:531-47.
- [736]Menon SC, Michels VV, Pellikka PA, Ballew JD, Karst ML, Herron KJ, et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. Clin Genet. 2008;74:445-54.
- [737]Halliday BP, Cleland JGF, Goldberger JJ, Prasad SK. Personalizing risk stratification for sud- den death in dilated cardiomyopathy. Circulation. 2017;136:215-31.
- [740]Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycar- dia-AMIOVIRT. J Am Coll Cardiol. 2003;41:1707-12.
- [741]Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defibril- lator implantation in patients with nonischemic dilated cardiomyopathy for the defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE) investigators. N Engl J Med. 2004;350:2151-8.
- [742]Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implant- able cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37.
- [743]Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221-30.
- [745]Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JGF, et al. Prediction of mode of death in heart failure: the Seattle heart failure model. Circulation. 2007;116:392-8.
- [747]Spezzacatene A, Sinagra G, Merlo M, Barbati G, Graw SL, Brun F, et al. Arrhythmogenic phe- notype in dilated cardiomyopathy: natural history and predictors of life-threatening arrhyth- mias. J Am Heart Assoc. 2015;4:e002149.
- [750]Van Rijsingen IAW, Van Der Zwaag PA, Groeneweg JA, Nannenberg EA, Jongbloed JDH, Zwinderman AH, et al. Outcome in phospholamban R14del carriers results of a large multi- centre cohort study. Circ Cardiovasc Genet. 2014;7:455-65.
- [754]Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309:896-908.
- [755]Di Marco A, Anguera I, Schmitt M, Klem I, Neilan T, White JA, et al. Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopa- thy: systematic review and meta-analysis. JACC Heart Fail. 2017;5:28-38.
- [758]Merlo M, Gobbo M, Stolfo D, Losurdo P, Ramani F, Barbati G, et al. The prognostic impact of the evolution of RV function in idiopathic DCM. JACC Cardiovasc Imaging. 2016;9:1034-42.
- [760]Goldberger JJ, Subačius H, Patel T, Cunnane R, Kadish AH. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2014;63:1879-89.
- [761]Zecchin M, Merlo M, Pivetta A, Barbati G, Lutman C, Gregori D, et al. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?". Am J Cardiol. 2012;109:729-35.
- [762]Losurdo P, Stolfo D, Merlo M, Barbati G, Gobbo M, Gigli M, et al. Early arrhythmic events in idiopathic dilated cardiomyopathy. JACC Clin Electrophysiol. 2016;2:535-43.
- [763]Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, et al. Use of the wear- able cardioverter defibrillator in high-risk cardiac patients data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II registry). Circulation. 2015;132:1613-9.
- [765]Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail. 2014;16:317-24.
- [766]McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin- neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993-1004.
- [768]Hare JM, DiFede DL, Castellanos AM, Florea V, Landin AM, El-Khorazaty J, et al. Randomized comparison of allogeneic vs. autologous mesenchymal stem cells for non-ischemic dilated car- diomyopathy: POSEIDON-DCM trial. J Am Coll Cardiol. 2017;69:526-37.
- [769]Woitek F, Zentilin L, Hoffman NE, Powers JC, Ottiger I, Parikh S, et al. Intracoronary cyto- protective gene therapy: a study of VEGF-B167 in a pre-clinical animal model of dilated car- diomyopathy. J Am Coll Cardiol. 2015;66:139-53.
- [771]Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67:2996-3010.
- [775]Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305-24.
- [781]Pérez-Molina JA, Molina I. Chagas disease. Lancet. 2018;391:82-94.
- [783]de Andrade JP, Marin Neto JA, de Paola AAV, Vilas-Boas F, Oliveira GMM, Bacal F, et al. I Latin American guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol. 2011;96:434-42.
- [784]Rassi A, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease. Circulation. 2007;115:1101-9.
- [785]Fish AE, Pride YB, Pinto DS. Lyme carditis. Infect Dis Clin North Am. 2008;22:275-88.
- [800]Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopa- thy. N Engl J Med. 2000;342:1077-84.
- [801]Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 European Society of Cardiology position paper on cancer treatments and cardiovas- cular toxicity. Eur Heart J. 2016;37:2768-801.
- [804]Ware JS, Amor-salamanca A, Tayal U, Govind R, Serrano I, Pascual-figal DA, et al. Genetic etiology for alcohol-induced cardiac toxicity. J Am Coll Cardiol. 2018;71:2293-302.
- [811]Guzzo-Merello G, Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Alcoholic cardio- myopathy. World J Cardiol. 2014;6:771-81.
Cited by
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments
Orphanou, N., Papatheodorou, E., & Anastasakis, A. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10139-0 · Cited by 137
Disease-Specific Health Disparities: A Targeted Review Focusing on Race and Ethnicity
Cullen, M. R., Lemeshow, A. R., Russo, L., Barnes, D. M., Ababio, Y., & Habtezion, A. (2022) · Healthcare · doi:10.3390/healthcare10040603 · Cited by 59
Inherited Arrhythmias in the Pediatric Population: An Updated Overview
Mariani, M. V., Pierucci, N., Fanisio, F., Laviola, D., Silvetti, G., Piro, A., Fazia, V. M. L., Chimenti, C., Rebecchi, M., Drago, F., et al. (2024) · Medicina · doi:10.3390/medicina60010094 · Cited by 46
“VA is infrequently found to be the root of HF in children [110].”
BackgroundRisk stratification in cardiomyopathy
Sinagra, G., Carriere, C., Clemenza, F., Minà, C., Bandera, F., Zaffalon, D., Gugliandolo, P., Merlo, M., Guazzi, M., & Agostoni, P. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320961898 · Cited by 37
Self-citationDilated cardiomyopathy: a new insight into the rare but common cause of heart failure
Giri, P., Mukhopadhyay, A., Gupta, M., & Mohapatra, B. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10125-6 · Cited by 33
Metadata
- Authors
- Sinagra, G., Merlo, M., & Pinamonti, B.
- Affiliations
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
- ORCID
- Gianfranco Sinagra
- Venue
- Springer eBooks
- Publisher
- Springer International Publishing
- Published
- 2019
- OpenAlex
- W4313642785
- Cited by
- 32
- References
- 603
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 9 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 2
- FWCI
- 5.48
- Type
- book
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Springer eBooks (publishedVersion, cc-by)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
- Directory of Open access Books (OAPEN Foundation) (submittedVersion, cc-by)
- Funders
- ACRC - Associazione Culturale per la Ricerca in Cardioscienze
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- dilated cardiomyopathy, pathophysiology, differential diagnosis, clinical management, genetic testing, cardiac arrhythmias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.